Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
08/2011
08/11/2011US20110196149 Fluoridation method
08/11/2011US20110195999 Novel antifungal agent containing heterocyclic compound
08/11/2011US20110195997 Dicarboxamide Derivatives
08/11/2011US20110195994 Piperidinyl GPCR Agonists
08/11/2011US20110195993 Ppar agonist compounds, preparation and uses
08/11/2011US20110195983 Quinazolinone derivatives useful as vanilloid antagonists
08/11/2011US20110195980 Bicyclic Kinase Inhibitors
08/11/2011US20110195964 Novel cyclic benzimidazole derivatives useful as anti-diabetic agents
08/11/2011US20110195963 Novel carbamoyloxy arylalkanoyl arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
08/11/2011US20110195960 Inhibitors of c-fms kinase
08/11/2011US20110195956 Heterocyclic Kinase Inhibitors
08/11/2011US20110195954 Novel compounds
08/11/2011US20110195940 Protease Inhibitors Having Enhanced Features
08/11/2011US20110195939 Antitumor properties of no modified protease inhibitors
08/11/2011US20110195930 Pyridine derivative or its salt, pesticide containing it and process for its production
08/11/2011US20110195110 Urea compounds useful in the treatment of cancer
08/11/2011US20110193074 Novel compound and organic device using same
08/11/2011US20110193064 Diaminopyrene derivative and organic el device using the same
08/11/2011CA2789279A1 1,2,4-triazine-4-amine derivatives
08/10/2011EP2354133A1 Method for producing 1-(3-Cyano-3,3-diphenylpropyl)-4-(1-piperidyl)-piperidine-4-carboxamide (Piritramide)
08/10/2011EP2354126A1 Heteroaryl sulfonamides and CCR2
08/10/2011EP2354124A2 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
08/10/2011EP2354120A1 Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
08/10/2011EP2353593A1 Non-nucleoside reverse transcriptase inhibitors
08/10/2011EP2352730A2 Biologically active amides
08/10/2011EP2352729A1 Melanocortin receptor antagonist compounds, process for preparing them and use thereof in human medicine and cosmetics
08/10/2011EP2352728A1 Melanocortin receptor modulators, process for preparing them and use thereof in human medicine and cosmetics
08/10/2011EP2352374A1 Novel cyclic benzimidazole derivatives useful anti-diabetic agents
08/10/2011EP2229378B1 Fluorescent, heterocyclic annellated perylene
08/10/2011EP2203431B1 Anti-infective pyrimidines and uses thereof
08/10/2011EP2197854B1 A new class of histone deacetylase inhibitors
08/10/2011EP2190815B1 Pyrrolidine aryl-ether as nk3 receptor antagonists
08/10/2011EP1948603B1 Tetrahydroindole derivatives for treatment of alzheimer's disease
08/10/2011EP1928840B1 1H-Pyrazole-4-carboxamides, their preparation and their use as 11-beta-hydroxysteroid dehydrogenase inhibitors
08/10/2011EP1841760B1 Pyrimidine derivatives as kinase modulators and method of use
08/10/2011EP1830853B1 Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases
08/10/2011CN1551878B 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
08/10/2011CN102149709A Novel crystal forms of 4-(2-aminopyridin-4-yl)-3-(4-fluorophenyl)-1-(1,4,5,6-tetrahydro-6-oxopyridazin-3-yl)-1H-pyrazole methanesulfonate and methods for their preparation
08/10/2011CN102149708A Pyrrolidin-2-ones as HDM2 ligands
08/10/2011CN102149707A Imidazole and triazole compounds, use thereof and agents containing said compounds
08/10/2011CN102149706A Antineoplastic derivatives of 4-oxo-L,4-dihydro-quinoline, preparation thereof, and therapeutic use thereof
08/10/2011CN102149705A [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-[7-fluoro-1-(2-methoxy-ethyl)-4-trifluoromethoxy-1H-indol-3-yl]-methanone as an inhibitor of mast cell tryptase
08/10/2011CN102149688A New benzimidazole derivatives
08/10/2011CN102149685A Isoquinolinone derivatives as NK3 antagonists
08/10/2011CN102146095A Pyrrole indolone compounds and preparation method and use thereof
08/10/2011CN102146084A 3-cyan-6-aminoquinoline derivatives, preparation method thereof and application thereof in medicines
08/10/2011CN102146074A Preparation method of pyrrole derivative and application thereof
08/10/2011CN102146073A New preparation method of alpha crystal form of imatinib mesylate
08/10/2011CN102146056A N-benzyl-acridone, derivatives of N-benzyl-acridone and preparation methods and application of N-benzyl-acridone and derivatives
08/10/2011CN102146054A Piperlongumine derivatives and medicinal composition and application to preparation of medicament for inhibiting tumor growth thereof
08/10/2011CN102146053A 2-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of inflammatory or immunological disorders
08/10/2011CN101107242B 阿立哌唑的盐 Aripiprazole salt
08/09/2011US7994333 Methods and compositions for selectin inhibition
08/09/2011US7994332 Process for producing crystal
08/09/2011US7994327 Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compounds
08/09/2011US7994326 For treatment of various forms of neurodegeneration, including that from stroke, Alzheimer's disease, Parkinson's disease, and Huntington's disease
08/09/2011US7994316 1,3,5-triazine derivative, production method thereof and organic electroluminescence device comprising this as a composing component
08/09/2011US7994204 Binding inhibitor of sphingosine-1-phosphate
08/09/2011US7994201 Anthranilamide compounds, process for their production and pesticides containing them
08/09/2011US7994200 Cycloalkane-substituted pyrazoline derivatives, their preparation and use as medicaments
08/09/2011US7994199 Heterocyclic compounds, methods for the preparation thereof, and uses thereof
08/09/2011US7994198 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase
08/09/2011US7994196 Indazole compound and pharmaceutical use thereof
08/09/2011US7994190 Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
08/09/2011US7994182 Quinazolinone-derivatives and their use for preparation of pharmaceutical compositions having PARP enzyme inhibitory effect
08/09/2011US7994177 Therapeutic agents useful for treating pain
08/09/2011US7994176 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
08/09/2011US7994175 Cosmetic use of 1-aroyl-N-(2-oxo-3-piperidinyl)-2-piperazine carboxamides and related compounds
08/09/2011US7994167 Pentafluorosulphanyl-substituted compound and its use for producing medicaments
08/09/2011US7994163 6-substituted-2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists
08/09/2011US7993663 Cosmetic use of 1-aroyl-N-(2-oxo-3-piperidinyl)-2-piperazine carboxamides and related compounds
08/09/2011CA2688709C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
08/09/2011CA2688708C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
08/09/2011CA2688695C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
08/09/2011CA2688694C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
08/09/2011CA2687924C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
08/09/2011CA2617991C N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
08/09/2011CA2572208C 3-carbamoyl-2-pyridone derivative
08/09/2011CA2551508C Novel quinoline derivatives
08/09/2011CA2539707C Quinoline potassium channel inhibitors
08/09/2011CA2537092C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
08/09/2011CA2520027C 2,3,6-trisubstituted-4-pyrimidone derivatives
08/09/2011CA2441492C Rho-kinase inhibitors
08/09/2011CA2422589C Pyridazinone and triazinone compounds and use thereof as pharmaceutical preparations
08/04/2011WO2011094545A2 Compositions and methods for enhancing proteasome activity
08/04/2011WO2011094496A2 Trypsin-like serine protease inhibitors, and their preparation and use
08/04/2011WO2011094260A2 Novel bifunctional metnase/intnase inhibitors and related compositions and methods of treatment of cancer
08/04/2011WO2011093924A1 Bicyclic heteroaryl inhibitors of pde4
08/04/2011WO2011093603A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
08/04/2011WO2011093524A1 Di - substituted pyridine derivatives as anticancers
08/04/2011WO2011093501A1 Gpr119 agonist
08/04/2011WO2011093365A1 Nitrogenated heterocyclic compound
08/04/2011WO2011092695A1 Quinazoline-based t cell proliferation inhibitors
08/04/2011WO2011092665A1 Process for the preparation of crystalline forms of dexlansoprazole
08/04/2011WO2011092198A1 5-alkynyl-pyrimidines
08/04/2011WO2011092197A1 5-alkynyl pyrimidines and their use as kinase inhibitors
08/04/2011WO2011092187A1 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
08/04/2011WO2011092088A1 Sulfonamido derivatives of 3,4-diarylpyrazoles as protein kinase inhibitors
08/04/2011WO2011091840A2 Materials for organic electroluminescent devices
08/04/2011WO2011041747A3 Neutral mixed ligand transition metal complexes as active materials in solid-state organic photovoltaic devices